Invest Securities maintains its 'neutral' rating on Qiagen shares, with a target price slightly reduced from 45 to 43 euros.

Q1 results came as no surprise, in line with previous quarters.

Among the 5 growth pillars, QTF, QIAstat and QIAcuity continue to stand out, while the Sample Tech division should rebound in H2 and a strategic decision could be announced on NeuMoDx by the time of the CMD on June 17', says the analyst.

While 2024 targets have been reiterated, Invest is lowering its target due to the higher WACC (Weighted Average Cost of Capital), and is keeping its estimates 'virtually unchanged'.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.